|Articles|January 1, 2003
FDA Brief
The FDA has approved what is said to be the first soft artificial cornea (AlphaCor, Argus Biomedical Pty. Ltd., Perth, Western Australia) for sale in the United States.
Advertisement
Newsletter
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
Evolving glaucoma therapy: A new era of interventional strategies
2
Development of maculopathy associated with systemic medications
3
STAAR postpones Alcon merger vote, Broadwood calls for removal of board members
4
Proactive strategies and sustained delivery advance glaucoma care
5













































.png)


